Page last updated: 2024-08-23

amikacin and Benign Symmetrical Lipomatosis

amikacin has been researched along with Benign Symmetrical Lipomatosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Delvaux, B; Dubois, PE; Gilliard, V; Russell, K	1

Other Studies

1 other study(ies) available for amikacin and Benign Symmetrical Lipomatosis

Article	Year
Long-lasting potentiation of a single-dose of rocuronium by amikacin: case report. Acta anaesthesiologica Belgica, 2006, Volume: 57, Issue:2 Topics: Amikacin; Androstanols; Anesthesia Recovery Period; Anti-Bacterial Agents; Drug Synergism; Female; Humans; Lipomatosis, Multiple Symmetrical; Lumbar Vertebrae; Middle Aged; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Rocuronium; Spinal Fusion; Time Factors	2006

Article

Year

Long-lasting potentiation of a single-dose of rocuronium by amikacin: case report.

Acta anaesthesiologica Belgica, 2006, Volume: 57, Issue:2

Topics: Amikacin; Androstanols; Anesthesia Recovery Period; Anti-Bacterial Agents; Drug Synergism; Female; Humans; Lipomatosis, Multiple Symmetrical; Lumbar Vertebrae; Middle Aged; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Rocuronium; Spinal Fusion; Time Factors

2006